Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
HAPPLYZ Medical - LORIO, respiratory rehabilitation 🎮 Breathe&Play, the new playful way to rehabilitate your respiratory system 🚀 Patented solution #videogames #medtech Step into the world of connected healthcare ! 394 millions people suffering from chronic respiratory diseases. Less than 10% of them regularly engage in respiratory rehabilitation, primarily due to lack of motivation. We have developed our first medical device from A to Z, LORIO, dedicated to monitored and gamified respiratory rehabilitation. LORIO is available in different versions for various purposes: at home, in medical practices, or collectively in rehabilitation centers. LORIO is a digital solution designed to improve the breathing capacity of these patients in … Type: Startup Activities: deeptech games healthtech manufacturing Technologies: Synthetic Biology | 52 | 16 | 43 | 5 | |
Coral Biome PHARMA CORAL BIOME PHARMA Live cultured corals for Drug discovery Coral Biome is a research and development company dedicated to the discovery of marine natural products of interest for major public health issues such as cancer, inflammation and multi-drug resistant infectious diseases. Our multidisciplinary team of research and worldwide network of collaborators gathers a unique set of competitive expertise including, aquaculture, marine biology, chemistry, cell biology and cancerology to successfully isolate marine natural products and test their biological activity. We maintain a large-scale untapped reservoir of coral species to preserve endangered species, sell corals for aquarium trade (http://www.coralbiome.com/aquaculture/) and provide research … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 2 | |
DelleD - LaFleur [Automatic translation follows] Serving patients and research. French hub for medical cannabis and dermo-cosmetic innovation Created in 2014 by a patient, DelleD is developing LaFleur Laboratories, the first French pharmaceutical laboratories specializing in medical cannabis & hortimind, an AI-assisted plant production solution. LaFleur aims to promote research and development of medical cannabis in France and internationally and to defend the evolution of the legal framework relating to the production, cultivation and use of cannabis for medical use. The laboratories cultivate, transform, control and manufacture medicinal products based on medical cannabis as part of research and development in France. Experts in … Type: Startup Activities: deeptech healthtech biotech manufacturing Technologies: Synthetic Biology | 17 | 4 | 12 | 11 | |
Relax "Diffuseur de bonne humeur" [Automatic translation follows] Relax "Good Mood Diffuser"® an alternative to medication in the management of stress and anxiety. RELAX, the result of a collaboration with experts in interventional cardiology, was developed to meet the needs of medical services. This innovative therapeutic reality solution aims to alleviate stress and anxiety associated with anxiety-provoking situations, including medical care and interventions. Designed with 2D relaxation glasses, RELAX technology offers a side-effect-free approach, suitable for a wide audience. These glasses can be used preventively before a medical procedure, during it to soothe the patient's anxiety, and afterwards to promote emotional recovery. Their usefulness extends … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 14 | 3 | 12 | 7 | |
KetoM+ Ketogenic Medical Food DADFMS R&D Facilitate Therapeutic Ketogenic Diets. KetoM+ : Ketogenic Medical Food DADFMS KetoM+ develops a new generation of ketogenic products adapted to therapeutic diets. Ketogenic diets can be challenging to manage for some populations (pediatric and adults) because of the high fat low carb ratio. Many neurological disorders like epilepsy have no real effective treatment. Metabolic diets have powerful therapeutic potential when well done. KetoM+ brings the solution with medically adapted products elaborated with a pharmaceutical approach. KetoM+ high quality ingredients and the respect to the palatability of the products make them unique. Medical Nutrition, Ketogenic diets … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 9 | 6 | 1 | 3 | |
Music Care CARE COMPOSER: for a significant reduction in pain, anxiety and the use of medication MUSIC CARE® develops innovative tools for the prevention and management of pain, stress, anxiety and depression. The MUSIC CARE® health device is a turnkey therapeutic management offer validated by a series of controlled clinical studies. Accessible to all professionals, our assistance and support solutions open up innovative perspectives for the world of health and well-being. MUSIC CARE® is now present in numerous hospitals, private clinics, senior citizens' homes and spa centers. Our strengths * Effectively manage pain*, anxiety, stress and depression * Significantly reduce drug consumption … Type: Startup Activities: healthtech silvertech Technologies: Synthetic Biology | 8 | 3 | 5 | 15 | |
INDIENOV [Automatic translation follows] Innovate to protect INDIENOV (commercial brand of HIPPY MS) designs and develops medical devices based on built-in electronics and artificial intelligence in order to extend the quality of life and independence of elderly people. INDIENOV (commercial brand of HIPPY MS) is an innovative company combining human and digital to save lives and serve better living. Its purpose, as a mission-driven company, is to contribute to the independence and promote the autonomy of people at risk by innovating in all ways. We act in this way to improve the safety, serenity and existence of people at risk and … Type: Startup Activities: healthtech manufacturing Technologies: Synthetic Biology | 36 | 12 | 26 | 19 | |
MImAbs SAS Innovative start up developing monoclonal antibodies in cancer and inflammatory diseases MImAbs is an innovative start-up specialized in immunotherapy. Our goal is to develop monoclonal antibodies in cancer and inflammatory diseases for third parties (academics, pharmacuetical companies, biotechnologies, etc.) Anticorps monoclonaux, Immuno-pharmacologie, Génération et bioproduction d'anticorps, and Génération d'immunoconjugués Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 3 | 2 | 33 | |
Lamina Therapeutics Developing innovative implantable medical devices for orthopaedic applications Lamina Therapeutics is a pioneering biotechnology company, developing innovative medical devices promoting patient's active live. Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions. Lamina’s lead product lamina.ONE, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function, is expected to enter phase I/II … Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology | 5 | 2 | 1 | 4 | |
Healshape A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology | 23 | 18 | 17 | 21 | |
Flash BioSolutions CDMO expert specialized in gene delivery Flash BioSolutions is a World-class CDMO expert in lentiviral vector manufacturing : With our continuum from research to the clinic we support you throughout your projects from R&D to GMP grade. We provide purified and highly concentrated particles from small scale to large scale with the same vector specifications. Flash BioSolutions provides integrative lentiviral vectors and RNA particles. Lentiviral vectors - LentiCare® : Conventional lentiviral vectors, which lead to DNA integrated into the genome, are a leading delivery method for applications which require a stable and long-term gene expression. Ideal for Gene Therapy and … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 22 | 3 | 9 | 50 | |
Cell-Easy Your science-driven CDMO dedicated to Cell Therapy Cell Easy is a rapidly growing Contract Development and Manufacturing Services organization (CDMO) with a dedicated focus on Advanced Cell Therapies. Established in 2017, Cell Easy's commitment extends beyond development and manufacturing; it also places a strong emphasis on regulatory and analytical aspects. Cell Easy offers a comprehensive suite of services, including process development, process scale-up, cGMP manufacturing, and analytical support for immune cells (engineered CAR-T, NK cells, and non-engineered cells) as well as adult stem cells (MSCs, iPSCs, and Exosomes). Our company has achieved significant milestones, such as advancing programs to Phase … Type: Startup Activities: biotech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 41 | |
Cellectis Cellectis is developing life-changing product candidates to target and eradicate cancer cells. Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 24 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells. As part of its commitment to a cure, Cellectis remains … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 19 | 6 | 8 | 231 | |
CapEval Pharma CapEval Pharma, founded in 2010, provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. In addition, CapEval provides expert assessment for due diligence, veterinary drugs, cosmetics, agrochemicals and chemicals as well as staff training. Drawing on > 60 years of combined international experience, we are a team of highly qualified pharmaceutical consultants, fluent in 5 languages. We provide scientific advice and training to identify the best approach to move your projects quickly through development and onto the commercial market. With experience working … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 0 | 2 | |
Cosmosoft Slimming devices for professionals and individuals Cosmosoft is a French designer, manufacturer and distributor of professional slimming equipment for more than 15 years. Created in 1998 by Cosmosoft, this technique provides a 100% natural way of stimulating the release of adipose cells for aesthetic and therapeutic purposes by activating the cells with a BioMagnetic field. Presents in the world with more than 2000 equipped centers, Cosmosoft devices are marketed through 3 divisions : - Beauty devices : BodySculptor & LipiDrainor slimming devices - Medical devices : ReduStim, a class IIa medical devices for reducing abdominal fat. - Fitness : MyoSculptor, … Type: SMB Activities: healthtech fashtech Technologies: Synthetic Biology | 1 | 0 | 0 | 9 | |
Beta Innov [Automatic translation follows] Development in Immunology and Cancerology of innovative drugs with curative potential. Beta Innov SAS is an innovative pharmaceutical Research and Development company, created in March 2009 by families of patients. Beta Innov aims to achieve a major therapeutic leap in the treatment of autoimmune diseases and Glioblastoma by using a physiological (Immunology) or metabolic (Glioblastoma) approach avoiding the costs of gene therapies and the adverse effects of antibody therapies. Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
Verona Pharma Developing life enhancing treatments for chronic respiratory diseases Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. If successfully developed and approved, Verona Pharma's product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. Ensifentrine met the primary endpoint in both ENHANCE-1 and ENHANCE-2 trials demonstrating statistically significant and clinically meaningful improvements in lung function. In addition, ensifentrine significantly reduced the rate of COPD exacerbations in ENHANCE-1 … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 190 | |
Graftys Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in particular new generations of resorbable calcium-phosphate cements, for reconstructive orthopedic surgery. The Company’s products are commercialized in more than 25 countries, including Europe and the United States of America, through distribution partnership. The objective of the Company is to expand the Company product lines by offering new versions of existing products and new products with enhanced regenerative properties. The Company is based in Belgium (Wallonia) and France (Nantes and Aix-En-Provence). bone graft substitutes, Bone void fillers, Orthopedics, Reconstructive orthopedic surgery, Trauma, Bone tissue engineering, Injectable bone substitutes, … Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 2 | 2 | 0 | 18 | |
ALCIS ALCIS IS YOUR PARTNER, from idea to medical market. You have an idea, a concept, a patent, a prototype... Alcis offers you its expertise and equipment to help you achieve your project and have a certified medical device, ready to be marketed. With more than 20 years-experience in the medical device sector, Alcis can provide you with an EC-marked product, from class I to class III, fostering your activity launch and your product development. We can also set up your quality management system and take the role of legal manufacturer. We can manufacture your medical devices within a controlled atmosphere … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 3 | 2 | 1 | 71 | |
Intégrateurs Industriels du Grand Défi Biomédicaments [Automatic translation follows] support for technological innovation for the production of biomedicines There are 6 of them, the Industrial Integrators of the Grand Défi Biomédicaments have the following missions: - to provide project leaders for the development of technologies for the production of biomedicines (new cellular and a-cellular expression systems, online control, new equipment) with the skills and tools required in the production of antibodies, gene therapy vectors, and cell therapies for the successful completion of their projects, - to provide access to standard bioproduction equipment and an environment conducive to research into the transformation of bioproduction equipment and processes, … Type: Incubators & VCs Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | N/A | |
ANS Biotech Our Services are as Unique as Your Discoveries ANS Biotech, a preclinical CRO dedicated to pain pharmacology, supports drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with: • Clinically relevant in vivo models for successful R&D of innovative analgesics, especially in the field of inflammatory pain, neuropathic pain and visceral pain ; • Customized scientific studies meeting drug discovery and development objectives ; • Consulting activities. ANS Biotech also offers ALGOGramTM, a unique in vivo screening tool that provides a rapid and cost-effective means to systematically explore pain indications … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 3 | 2 | 1 | 23 | |
Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 9 | |
ASKORN MEDICAL Experts in medical devices design & development, quality assurance and regulatory affairs. Design, development and manufacturing of medical devices, from class I to class III. Consulting on Quality Assurance and Regulatory Affairs ISO 13485 : 2016 certified company by French Notified Body GMED. Registered with the FDA. Affaires réglementaires, Conseil en qualité, and Conception de dispositifs médicaux classe I à III Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 6 | |
Groupe d'Étude et de Promotion des Protéines Végétales [Automatic translation follows] Long live plant proteins! The GEPV, with the support of interprofessional organizations, supports the development of plant proteins by actively participating in a better understanding of these products. VPMs (plant protein materials) are food ingredients from plant species rich in proteins, such as legume seeds (soy, udder, lupin, fava bean) and cereal seeds (wheat). Type: SMB Activities: foodtech Technologies: Synthetic Biology | 5 | 1 | 5 | N/A | |
Sebia France [Automatic translation follows] The world leader in protein separation using innovative electrophoresis systems Sebia France is a subsidiary of the Sebia Group. Founded in 1967, Sebia is a global player specializing in in vitro diagnostics for the screening and monitoring of various diseases, mainly in the fields of oncology (multiple myeloma), diabetes, hemoglobinopathy, autoimmunity and other rare pathologies. Sebia’s mission is to provide powerful tools that translate what is happening in a patient’s body into a readable and interpretable language. We call it our new language of life. Based in the south of Paris (Lisses, France), we have set strict … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 518 | |
Electronique du Mazet [Automatic translation follows] Designer and manufacturer of electro-medical devices Electronique du Mazet designs and manufactures electronic products. Specializing in the medical sector, the company takes care of the design and manufacture of complete products for its customers. It has also developed a range of products intended for physiotherapists and sold under its Mazet Santé brand. Medical Device and Electronic Cards Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 35 | |
Mazet Santé [Automatic translation follows] Your partner in physiotherapy. Do not hesitate to contact us for more information! Mazet Santé is a brand of the Electronique du Mazet group. Located on the Lignon plateaus in Haute-Loire (near Saint-Etienne) for 40 years, the company Electronique du Mazet has become an expert in the design and manufacturing of 100% French quality medical devices. Our products benefit from the CE Medical 0459 certification and the ISO 13485 standard and are mainly dedicated to physiotherapy. You can also find us on Facebook and YouTube. Mazet Santé is a brand of the Electronique du Mazet group. Based … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 3 | |
Aguettant France [Automatic translation follows] Essential for life Bienvenue sur la page LinkedIn AGUETTANT France ! AGUETTANT is a French family pharmaceutical laboratory dedicated to the development, fabrication and marketing of injectable pharmaceutical specialties used or initiated at the hospital. AGUETTANT with its expertise in the service of progress and medical innovation to design the therapeutic solutions of tomorrow. Retrouvez sur cette page toute l'actualité d'AGUETTANT France. Anesthésie - Réanimation, Nutrition Parentérale, Produits Injectables d'Urgence, Maladie de Parkinson, and Spasticité Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 1 | 1 | 88 | |
CAP COMPLIANCE [Automatic translation follows] CONSULTING, AUDIT, SPECIALIZED TRAINING HEALTHCARE INDUSTRY - medical devices, cosmetics, food supplements, med. CAP COMPLIANCE is a consulting company specializing in QUALITY Management. Its core business focuses mainly on consulting activities for the healthcare industries (medicines, medical devices, cosmetics and food supplements). Founded by an independent consultant who has built up his professional experience over fifteen years in the healthcare industries, Cap Compliance is now able to provide you with all the necessary solutions to best comply with the standards and benchmarks related to the healthcare industries. CONSULTING - AUDIT - TRAINING 🗞 CAP COMPLIANCE service offer: … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 3 | 2 | 3 | 7 | |
AveXis, Inc. AveXis is now Novartis Gene Therapies Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA). Follow us on LinkedIn: https://www.linkedin.com/company/novartis-gene-therapies/ How to reach us: Novartis Gene Therapies 2275 Half Day Road, Suite 200 Bannockburn, IL 60015 Email: gtx.communications@novartis.com Office Phone: 847.572.8280 Toll-free Phone: 844.428.3947 Gene Therapy, Synthetic Biology, and Spinal Muscular Atrophy Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 0 | 107 | |
Cell-Free Technology Ltd. We build biocomputers. We are hiring. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 0 | |
ARTCLINE GmbH Innovative therapeutic procedures for Intensive Care Medicine for the treatment of severe infections / sepsis ARTCLINE GmbH develops innovative therapy methods for intensive care medicine based on immune cells. Our current main project is the development of the so-called ARTICE technology for the treatment of bacterial sepsis. ARTCLINE's vision is the development of innovative immune cell-based therapy approaches and to make the technology available to physicians and hospitals worldwide. The safety and effectiveness of the therapy is our top priority. Our extensive cell biological, clinical and industrial experience in the fields of immunology, sepsis diagnostics and therapy help us to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 17 | |
ProteinDistillery Crafting Tomorrow's Proteins. Today! ProteinDistillery is a food-tech start-up which creates a new generation of clean and sustainable proteins for food companies using microorganisms. At ProteinDistillery we rethink a healthy and sustainable protein supply. We believe that it takes new technologies and products that enable the transition from linear to circular value chains to preserve our planet. With our innovative process we can purify proteins from residual yeast of the beer brewing process. Clean and various. Brewer’s yeast proteins are multiply applicable - from neutral-tasting foam for cappucchino to fibrous structure and spicy umami taste for meat substitutes. And all … Type: Startup Activities: foodtech Technologies: Synthetic Biology | 4 | 0 | 4 | 27 | |
Neupulse Improving the lives of people with Tourettes https://www.neupulse.co.uk Neupulse is the brand of Neurotherapeutics Ltd The direction of our current research was very much shaped by the feedback we received from individuals with tic disorders and their families. When we asked them for their thoughts on our research priorities we were frequently told that what was really needed was a safe and effective non-drug treatment for tic disorder that could be used outside of the clinic and gave individuals control over their tics. This led directly to us focusing on the use of peripheral nerve stimulation as a means of … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
NLS Pharmaceutics AG Connecting Brains WE ́RE NOT CURRENTLY HIRING MISSION & VALUES To serve our patients we design affordable, safe and effective therapeutics to safeguard and empower the brain throughout all stages of life. We value partnership and Integrity, we are ethical and responsible and show respect and compassion for our patients. R&D STRATEGY The successful companies of tomorrow are those that go beyond delivering products to delivering real solutions and services. R&D is the cornerstone of our company and we promote ingenuity through an effective intellectual property policy. The advancements in science mean that more targeted, more (cost-)effective treatments are within … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 7 | |
Eisbach Bio GmbH Targeting synthetic lethality in cancer Eisbach Bio is an innovative start-up in biotechnology founded in 2019 as a spin-out of the Biomedical Center Munich. We are developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes. Eisbach will beat cancer at its own game. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 12 | |
CryoLogyx Revolutionizing cell-based assays with assay-ready cryopreservation solutions for faster, reliable results CryoLogyx specializes in developing and producing high-quality, cryopreservation solutions. The cryopreserved cells are designed to cater to the critical needs of the drug discovery, which is powered by the patented formulation - CryoshieldTM. Freezing and thawing processes can be particularly stressful for cells, often resulting in reduced viability and recovery due to ice crystal formation and other factors. And the repetitive tasks of cell culture, including numerous counting and handling procedures, take significant time that researchers could otherwise dedicate to more critical aspects of their research. At CryoLogyx, we … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 11 | |
FundaMental Pharma We Fight Neurodegeneration FundaMental Pharma is engaged in pioneering research around a breakthrough molecular mechanism that allows to safely counteract glutamate neurotoxicity (also known as excitotoxicity) by specifically targeting the interface between NMDA receptors and TRPM4 channels with small molecule TwinF interface inhibitors (Yan et al., Science 2020). TwinF interface inhibitors constitute an entirely new class of drugs that safely ameliorate glutamate neurotoxicity, a common cause of neurodegeneration. Our initial focus is on amyotrophic lateral sclerosis (ALS). The applicability of our molecules extends to a range of neurogenerative disorders including Alzheimer’s disease (AD). Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
NEOGAP Therapeutics AB Science for cure. NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy. Biopharmaceutical company, Immunotherapy, and Immuno-oncology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 26 | |
Onego Bio Onego Bio is a game changer food-biotech company producing animal-free egg protein with precision fermentation. Onego Bio is a US-Finnish food-biotech company revolutionizing the food system by harnessing the power of precision fermentation to manufacture real egg protein entirely animal-free. Their ingredient, Bioalbumen®, sets a new standard for sustainable protein with identical taste and nutrition, superior functional properties and over 90% smaller environmental footprint compared to eggs from chickens. Onego’s highly efficient and scalable technology caters to the needs of the food industry searching for stable, sustainable functional ingredients. As a game-changer in the field, the company was selected the … Type: Startup Activities: biotech deeptech agritech foodtech Technologies: Synthetic Biology | 4 | 2 | 1 | 44 | |
Bmind [Automatic translation follows] There are no pre-established paths for psychological well-being. BMind helps you design yours, step by step. BMind offers an online psychological support service accessible to all and efficient, tailor-made for each person. Our goal 💪🏼 There are no pre-established paths for psychological well-being, but Bmind wants to help people design theirs in a totally personalized way, without ever neglecting the individual differences of each patient. The perfect match exists ✅ The match between psychologist and patient occurs automatically but accurately and reliably, so that the professional can fully reflect the patient's needs and accompany them on their … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 16 | |
Oncostellae Novel small-molecule drugs in immunology, fibrosis and women health Clinical-stage biotech company founded by serial entrepreneurs and owned by private & institutional investors. Discovery and development of new chemical entities with strong IP and worldwide rights targeting indications with high unmet medical need in immunology, fibrosis and women health. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, Inflammation and autoimmune diseases, IP generation, IBD, Ulcerative Colitis, Crohn's disease, Fibrosis, and Uterine fibroids Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Asgard Therapeutics Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient. Cell Reprogramming, Cancer Immunotherapy, and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 25 | |
BRAINCURES Powering a drug discovery revolution to deliver cures for brain diseases that affect at least 1 in 10 people worldwide Brain diseases have no cures and affect 1 in 10 people worldwide and their families. BRAINCURES aims to tackle brain diseases with precision medicine based on the code for brain function. Our landmark decoding of the molecular framework behind brain health pinpointed SMART Target-Biology linkages that now empower novel translational avenues to conquer brain diseases through SMART Patient Stratification and SMART Treatments. The application of our proprietary platform technologies will lead to personalized treatments for the 350 million people worldwide … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 2 | |
Yuri Space biotech for a better life 🧫🚀 yuri is a space biotech company that uses the microgravity environment of space to develop and manufacture superior biotech products. The team of 30+ space engineers and biologists has worked on 20+ payloads for the International Space Station in collaboration with organizations like NASA, ESA, GSK, Charité Berlin. We develop modular bioreactors and incubators for cell cultures, protein crystals or plants and launch them for scientists around the world to the ISS and other spacecraft such as Sierra Nevada Dream Chaser or SpaceX Dragon. We also sell and rent devices to simulate microgravity … Type: Startup Activities: manufacturing spacetech Technologies: Synthetic Biology | 17 | 2 | 16 | 52 | |
VoltSafe Inc. A safer, simpler and smarter way to connect and control electricity. unplug. connect. At VoltSafe, we're fearless creators, obsessed with progress. Our products are unique and our technology is revolutionary in the field of electronics. And while everyone is infatuated with innovations at one end of the power cord, we’re obsessed with improving the other end to change how people connect to power. Simply put, we’ve discovered a smarter and safer way to connect to electricity using magnets. Importantly, our patented technology empowers retail producers, industries, governments and essential services to do their jobs more safely, efficiently and sustainably. Our … Type: Startup Activities: constructiontech smart home Technologies: A.I. IoT Sensors Synthetic Biology | 1 | 0 | 1 | 21 | |
Virtue Health Virtue is a digital therapeutics company developing new approaches to treat and prevent age-related diseases. health and health tech Type: Startup Activities: healthtech Technologies: Synthetic Biology | 3 | 3 | 0 | 1 | |
Ventec Life Systems Defining Integrated Respiratory Care Ventec Life Systems was recently acquired by React Health. For up to date information, please visit the React Health Linkedin Page. medical devices, life-support ventilators, ventilation, and portable ventilator Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 1 | 274 | |
TORSKAL 🌿 Green nanoparticles for cancer therapy TORSKAL is an international biotech/medtech company, a pioneer of green nanotechnology. We design disruptive gold nanoparticles for cancer therapy from green chemistry. We are committed to the development of a new generation of non-toxic and eco-friendly nanomaterials for the treatment of surface and deep cancers by green chemistry. We have discovered an innovative, green, and patented way of producing gold nanoparticles, leveraging Indian Ocean endemic plants, that have many applications in health. Main project: the Nanotheranostics Project (NT1), a treatment for skin cancer using near-infrared (IR) radiation-induced plasmonic phototherapy Deep Cancer program (NT2 & … Type: Startup Activities: nanotech biotech deeptech Technologies: Synthetic Biology | 11 | 4 | 9 | 4 | |
CONNECTA Therapeutics Promoting neuroplasticity modulation. CONNECTA Therapeutics S.L. is a biotechnology company that develops new treatments for CNS unmet medical needs. The company is initially focus on the clinical development of a new “first-in-class” molecule for the treatment of fragile X syndrome (FXS). FXS is the most common cause of hereditary intellectual disability and there are no therapeutic interventions currently available. The molecule was discovered after evaluating more than 30 molecular and cellular targets. The molecule has been proven, in in vitro tests and in vivo in animal models, to be an excellent neuroplasticity modulator with a great extension profile for other … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 7 | |
Shield Therapeutics plc Helping patients become people again Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol). The Group has launched Accrufer® in the US and Feraccru® is commercialized in the UK and European Union by Norgine B.V., who also have the marketing rights in Australia and New Zealand. Shield also has an exclusive license agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of Accrufer® / Feraccru® in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. in the Republic of Korea, and with … Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 74 | |
Tessellate BIO Redefining Synthetic Lethality beyond HRD Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion. drug discovery, precision oncology, and biotechnology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 27 | |
veprosa [Automatic translation follows] Upgrade your meal! veprosa sauces contain an extra portion of protein! ✅ organic ✅ purely plant-based ✅ gluten- and soy-free ✅ no added sugar vegan, sauce, functional food, protein, and plant-based Type: Startup Activities: foodtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
mk2 Biotechnologies Peptides & Proteins for Mass Applications mk2 Biotechnologies develops, produces and investigates peptides & proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides & proteins for a broad range of applications. Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
Repron Therapeutics Epigenetic silencing platform for tumor recurrence repression At Repron, we are developing an innovative strategy to inhibit the activity of oncogenes at the basis of tumor malignancy through the use of engineered synthetic factors. Oncogenic transcription factors activate thousands of target genes that, regulating processes like cell proliferation and invasiveness, make the cancer cells dangerous. By rational engineering of these factors, we exploit the natural binding ability to deliver repressive activity, instead of activation to their targets. Substituting the domain responsible for the activation with others featuring epigenetic inhibitory capabilities, we obtained Epigenetic Silencer Factors, that, once delivered in the … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
XTremedy Medical Developing the next infection treatments to help patients at risk of amputations get back on their feet faster XTremedy Medical is an early stage medical device company in Galway, Ireland. Our goal is to improve infection treatments for patients with deep musculoskeletal infections so patients can avoid amputations and get back on their feet faster. We are developing a completely disruptive surgical device that is up to 1000x more effective than the current standard of care. Our mission is to transform the musculoskeletal infection market to treat patients effectively in the first surgery. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 2 | |
Autolomous Pragmatic digital solutions for Cell and Gene Therapy Manufacturing Autolomous is a company founded by Cell and Gene Therapy (CGT)- and software development experts, who have combined their skills to deliver elegant, seamless and agile solutions to the CGT sector. Autolomous will deliver the digital solutions necessary for CGT to achieve scalability, allowing more patients to benefit from these life changing therapies. The company is creating a portfolio of software solutions (AutoloMATE-solution platform), from electronic Batch Manufacturing Records (eBMR) to enabling the scheduling of the patient blood collections at hospital; the transport of those cells to the manufacturing facilities; enhancing … Type: Startup Activities: deeptech it services Technologies: Synthetic Biology | 6 | 0 | 5 | 38 | |
Aliform Aliform is a VC-backed, clinical-stage medical device startup company developing new devices to make skin surgery safer, easier, and more accessible. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
GemViz, LLC MedTech Development GemViz, LLC is a MedTech development company serving the multi-billion dollar medical device market. The company is focused on digital solutions that drive deeper surgical insights and better patient outcomes. GemViz services include development and market strategies to take innovative ideas from concept to commercialization in the MedTech space. The leadership team has broad experience including medical device markets and products, digital ecosystems, decentralized blockchain style systems, internet of things, augmented and virtual reality, and data visualization methods. medical device, orthopedic, medtech, mixed reality, blockchain, internet of things, product development, technology, digital surgery, and virtual reality Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
SERio Roślinny ser Pierwszy na świecie roślinny ser z łubinu! Bogaty w białko, naturalne składniki, narodzony z pasji do roślinnej kuchni. World's first plant-based cheese made from the lupine bean. Rich in protein, clean label and real taste is what is most important to us! We are people with passion and we want to change the world by offering new possibilities and amazing food. Type: Startup Activities: foodtech Technologies: Synthetic Biology | 1 | 0 | 1 | 4 | |
Cellevate AB Innovative biotech company developing next generation of cell culture systems designed to revolutionize biomanufacturing Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3dTM - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3dTM carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 26 | |
Interrupt Biomedical and Engineering Inc. health technologies for everyone Interrupt Engineering is a medical device company known for its innovative products, including MoveMate, a wearable health technology designed to detect freezing of gait, a movement disorder commonly seen in Parkinson's patients. biyomedikal, elektronik, and medikal cihaz Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 7 | |
Stellate Therapeutics Stellate Therapeutics develops innovative microbiome-derived small molecules to treat neurodegenerative diseases. Stellate Therapeutics is a pre-clinical stage start-up company developing innovative microbiome-derived small molecules to treat neurodegenerative diseases. We utilize the microbiome for our drug portfolio and our research focuses on the gut-brain axis. Due to millions of years of co-evolution, complex metabolic interactions exist between humans and their gut bacteria and Stellate has uncovered a unique set of metabolites that are produced by the microbiome and are involved in the maintenance of health. Our first drug will be a treatment for Parkinson’s disease. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 9 | |
Diagnostics For Animals Federate and represent Manufacturers of Animal Health Diagnostics Promotes initiatives for the development of AHD Diagnostics For Animals is the only professional international #organization representing #animal #health #diagnostics. It federates and represents #manufacturers of animal health diagnostics at large, explains the benefit of an harmonized, efficient, and transparent regulatory framework to ensure the future #veterinary health industry and promotes initiatives for the development of animal health diagnostics health, animal, vet, veterinary, diagnostic, OneHealth, organization, livestock, pet, zoonosis, medical device, medical analysis, innovation, health security, research, and test Type: Startup Activities: pettech biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 3 | |
Nexbiome Therapeutics Become the next champion in microbiome therapeutics Nexbiome therapeutics: The first private incubator of microbiome biotech companies Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 3 | 0 | 6 | |
MATRIA Health Technologies Stop hemorrhage instantly. Immediate & efficient postpartum hemorrhage control. Device based on physiological action. MATRIA Health Technologies develops cutting-edge medical devices designed to control and stop postpartum hemorrhage, the leading cause of maternal deaths worldwide. Our innovations ensure patient safety without any biological or chemical side effects. Medical Device, Surgery, Emergency, Obstetrics, Postpartum Hemorrhage, PPH, Start-Up, Innovation, Chirurgie obstétrique, Gynécologie, Gynecology, Healthcare, and Dispositifs médicaux Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 6 | |
ONCOVITA Unleashing nature's own power to destroy cancer ONCOVITA is a biotechnology company based out of 28 RUE DU DOCTEUR ROUX, PARIS, France. Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 2 | 1 | 0 | 7 | |
Medjeduse - Spinal Cord Regeneration Research Restoring Movement and Sensation After Paralysis Medjeduse is a groundbreaking startup emerging from cutting-edge research at CNRS’s "Axonal Regeneration and Growth" team, focused on spinal cord repair. Unlike exoskeletons and brain interfaces that address symptoms without solving the root cause, we tackle spinal cord injuries directly. Our approach aims to provide a true solution for recovery rather than working around the problem. The need for effective spinal cord injury treatment is immense, with injuries leading to emergency hospitalizations, deaths, and chronic disabilities (paraplegia, tetraplegia), across all ages. Currently, there are no therapeutic solutions beyond long-term physical rehabilitation. Each year, 30,000 … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 2 | 0 | 4 | |
One Biosciences Focused on generating precision medicines by leveraging the power of single-cell technologies One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 5 | 5 | 17 | |
Seekyo Therapeutics Tumor Activated Therapy: targeting Tumor Micro-Environment functional proteins to induce tumor self-destruction The heterogeneity of cancer cells constitutes a strong limitation for the treatment of solid cancers like pancreas and Breast TNBC. Shifting to a new paradigm, Seekyo, a pre-clinical biotech Co. overpowers this challenge by targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME). Seekyo’s lead compound SKY01 induces a selective tumor self-destruction: • Efficacy and safety validated in small and large animals (e.g. Dogs). • Unprecedented antitumor efficacy vs. Standards of Care • Efficient in several tumors (Pancreas, Triple Negative Breast Cancer, lung, colorectal...) • Low … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 6 | |
Nanobiose Smart tools for cell biology Nanobiose’s mission is to provide pharma, biotech and cosmetic companies with better tools to improve their in vitro analysis of efficacy / safety of drug candidates. Nanobiose develops SecretCells®, an innovative lab-on-a-chip system to evaluate secreted biomarkers from 2D or 3D perfused cells. SecretCells® combines a microfluidic biochip (where the perfused 3D cell cultures stand) and a removable biosensor for a multiplexed on-line biomarkers analysis. While better mimicking in vivo like conditions, SecretCells® allows more accurate and more predictive results for the evaluation of drug candidates at early stages. SecretCells® is a very flexible solution … Type: Startup Activities: biotech deeptech Technologies: Sensors Synthetic Biology | 21 | 2 | 21 | 4 | |
Pasithea A New Approach to treat Sleep Apnea Pasithea: A New Approach to Sleep Apnea Pasithea introduces a novel and groundbreaking non-invasive adaptive neuromodulation approach to address respiratory disorders. The applied stimulation elicits a response from the autonomic nervous system in the early phases of apnea. Clinical studies have shown that Pasithea's therapy is safe and well-tolerated, and that it can significantly improve respiratory disorders. The therapy is also non-invasive, which means that it does not require surgery or hospitalization. Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 3 | |
TheraPPI Bioscience SAS Targeting protein interactions for health Founded in 2023, TheraPPI Bioscience is a biotechnology company whose science originates from the CRCL (Centre de Recherche de Cancérologie de Lyon, France). We modify protein interactions to offer treatments where current therapies fail. Our approach represents a paradigm shift in tackling cancer resistance and non-curable rare diseases protein-protein interaction, PPI, small molecule, therapeutics, oncology, and rare disease Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 3 | 0 | 4 | |
CILIATECH - Glaucoma Innovators Developing a new class of supraciliary implant for treating glaucoma CILIATECH is a medtech company specialized in ophthalmology, developing a new class of implant to address the increasing need to treat glaucoma durably with a novel design. Founded in 2017 by ophthalmic surgeon and inventor Dr. Philippe Sourdille and Olivier Benoit, a veteran engineer and biotech entrepreneur, CILIATECH developed the CID (Cilio-scleral Inter-positioning Device) groundbreaking concept ‘CID’ is the first implant in the industry to reduce IntraOcular Pressure (IOP) without needing to access the anterior chamber or create a subconjunctival filtration bleb. The device is implanted as a standalone procedure … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 7 | |
Myotact Innovation for patient autonomy Myotact is a medical device that detects muscle activity by EMG and translates it into virtual movement with vibrotactile feedback. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 23 | 5 | 22 | 1 | |
BariaTek BariaTek is a clinical stage company dedicated to treating obesity via a reversible non-invasive endoscopic approach. BariaTek Medical is a clinical stage company dedicated to addressing obesity via minimally invasive endoscopic approaches. Obesity is one of the most debilitating pandemics affecting humanity: More than 2 billion people are overweight of which 1 billion suffer from obesity. People suffering from obesity tend to lead shorter, less healthy, lives. Treating overweight-related conditions (diabetes, hypertension, sleep apnea and others) is projected to cost G-20 nations on average 8.7% of their health budgets over the next three decades which is estimated by the United … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 19 | |
ArkAb ArkAb is now Bcell Design! ArkAb is now Bcell Design! Bcell Design develops and manufactures chimeric monoclonal antibodies with human-like characteristics for in vitro diagnostics. We provide a secure and reliable source of raw material as a best alternative to disease state plasma and human serum, currently used as calibrators, positive controls or quality controls. Through its technological platform, built upon 15 years’ expertise in mAb and early-stage immunotherapy development, IVD developers and manufacturers gain access to a wide range of antibodies that are immediately ready for testing in human models. Founded in 2007 and from one of the few … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 10 | 1 | 48 | |
Cellforcure a NOVARTIS company CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an … Type: Startup Activities: healthtech deeptech biotech manufacturing Technologies: Synthetic Biology | 2 | 2 | 0 | 104 | |
NOXELIS Innovative ocular solutions Noxelis is a French ophthalmic medical device company dedicated in developing next-generation treatments, including polymers and hyaluronic acid as a cornerstone. Through its technological platform, Noxelis proposes different formulations aimed at improving medical practice and provides ophthalmologists with first-in-class therapies to treat ocular surface diseases. Noxelis was founded by a passionate and determined team to bring innovative technologies to market with one focus: Bring patients' ocular comfort to the next level. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 2 | 0 | 4 | |
Thabor Therapeutics Develops innovative treatments for mucosal inflammatory diseases Thabor's website Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 11 | |
CELLOMET CELLOMET provides cutting-edge R&D services on cellular metabolism for needs in industry and public institutions. CELLOMET is a spin-off CRO composed of internationally recognized experts in the field of cellular metabolism. Metabolism comprises crucial biological processes which enable breakdown of sugars, proteins, and lipids necessary to provide life-sustaining energy in all types of living organisms. CELLOMET has developed in-depth knowledge and cutting-edge technologies to address any particular metabolic modification occuring at the cellular level. This expertise can be applied to study the effects of pharmacological compounds or natural extracts in cosmetology, the impact of genetic modifications or nutrition, and the … Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology | 2 | 0 | 1 | 4 | |
SIGNIA THERAPEUTICS Breakthrough Solution for Respiratory Infections SIGNIA THERAPEUTICS is a research company based out of Bâtiment Adénine, 60 Avenue Rockefeller, 69008 Lyon, France Type: Startup Activities: deeptech Technologies: Synthetic Biology A.I. | 0 | 0 | 0 | 5 | |
Institut for Regenerative Medecine & Biothérapies (IRMB) Our mission is to change human health through a deep understanding of immune cells and stem cells biology.. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 37 | |
En Carta Diagnostics Diagnostics for better care, everywhere. Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions. synthetic biology, cell-free, biotech, and molecular sensing Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 5 | 3 | 3 | 6 | |
EYEVENSYS We create ophthalmic therapeutic bio factories to sustainably treat major eye diseases. Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease. EyeCET stands for the eye ciliary muscle electro-transfection technology, which uses electroporation to deliver plasmids coding for therapeutic proteins in the eye. EyeCET is safe and non-viral, and it enables the ciliary muscle cells to sustainably produce therapeutic proteins locally. Eyevensys believes its EyeCET technology can improve short and long-term therapeutic outcomes, greatly enhancing patient compliance and significantly … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
RESOLUTION Spectra Systems Leader in advanced optical spectroscopy with solutions dedicated to bioprocess Raman monitoring & laser characterization Leader in bioprocess analytical monitoring, RESOLUTION Spectra Systems is now part of Merck PAT, Raman spectroscopy, Chemometrics, Bioprocess, Bioprocess analytics, Cell culture monitoring, Upstream process development monitoring, Process Analytical Technology, Downstream processes control, In-line monitoring, and Real-time monitoring Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 8 | 2 | 8 | 3 | |
Abbelight [Automatic translation follows] From Microscopy to Nanoscopy _ Scalable bioimaging solutions and multiple expertise to speed-up your imaging projects Founded in 2016, Abbelight is a fast-growing company specialized in imaging solutions focusing on microscopy and unique single molecule detection (super-resolution). The portfolio integrates a constantly evolving knowhow on chemistry, optics and computer science to offer a complete solution, from sample preparation to data management, including an optimal bio-imaging platform that can be adapted to all researchers', biotech labs' and medical facilities' needs. Abbelight is a French company developed by four passionate researchers who aim to help improve human health in … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 6 | 8 | 51 | |
NERVOSAVE THERAPEUTICS Innovative therapies for peripheral nerve diseases Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 0 | 4 | |
Redberry SAS Industrial microbiology testing providing immediate results at performance and ease-of-use never reached before. Redberry offers rapid testing solutions aimed at avoiding the culture phase of microorganisms in industrial microbiology and thus providing immediate results at cost, performance and ease-of-use never reached before. We work with Pharmaceutical and Personal Care Product manufacturers. We also offer solutions for Water professionals and collectivities. Available applications : ►ATMP Release testing : Rapid 3-Level Approach ►Sterility testing for Pharma Products : 4 days results with full compendial sample preparation - Primary validation package available with full equivalency. ►Rapid Bioburden for in-process, raw materials, final products … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 19 | 8 | 16 | 19 | |
ANTINEO Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 1 | 4 | 12 | |
Defymed Advanced therapies inspired for you Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort. Defymed is a spin-off of the Centre européen d’étude du Diabète (European center for diabetes studies), which began work on a bioartificial pancreas in 1996. Today, Defymed focuses on diabetes, which is considered to be one of the major epidemics of the 21st century. There are currently two medical devices being developed by Defymed which are at an advanced preclinical trial phase: - #MailPan®: bioartificial … Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 28 | 7 | 24 | 3 | |
Synens Intelligent Drug Screening Synens is a French company that manufactures rapid on-site drug screening devices. We strive to deliver reliable and customizable drug test kits and analyzers. At Synens, adaptability is key. We meet the requirements of our clients and the regulations in force. Synens is the designer of the D1 Handheld Analyzer that is used internationally by law enforcement, fire departments, healthcare professionals and in workplaces. Technology, Drug Screening, and Drug of Abuse Detection Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
ANAQUANT Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 2 | 8 | |
CELLforCURE by Seqens Trustworthy development and commercial manufacturing of CELL&GENE therapies On december 1st 2023, Seqens completed the acquisition of CELLforCURE. Originally a versatile CELL&GENE CDMO, CELLforCURE gained thorough experience in commercial CAR-T cells manufacturing. With 2 200m2 GMP production areas, 6 equipped production suites and 180 seasoned highly skilled experts, CELLforCURE offers versatile and flexible capacities. Located in France, 20km away from the Paris Orly Airport, CELLforCURE is an EMA approved production site and is compliant with FDA standards. The site brings analytical, development and regulatory services to serve client needs across the overall product life cycle. CELLforCURE teams aim at partnering … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 4 | 2 | 2 | 57 | |
Dynacure Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. Dynacure is headquartered in … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 6 | 3 | 11 | |
SLS France [Automatic translation follows] SLS France is a company being created in the Rennes area. This structure will allow the manufacture of chrome-cobalt dental prostheses by micro-fusion. Based on a multidisciplinary team competent in this technology, our desire is to offer a quality product that perfectly meets the needs of our future customers. Type: Startup Activities: deeptech healthtech manufacturing Technologies: 3D Printing Synthetic Biology | 3 | 0 | 0 | 15 | |
EryPharm EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 1 | 8 | 4 | |
NEVEZYNE [Automatic translation follows] Nevezyne develops its own protein expression systems and offers its expertise in the expression of recombinant proteins, for research programs, for diagnosis in animal and human health Protein expression, Baculovirus system, Protein purification, and Bacterial system Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 1 | 1 | 3 | |
Natura Meliss' [Automatic translation follows] A zero-waste and natural bathroom “Mixed, healthy and effective products based on Ayurvedic plants” The idea of Natura Méliss’ was born after a 15-year experience as an engineer in a pharmaceutical Research and Development laboratory. I was not convinced by the cosmetics I found on the market. So I decided to look for solutions. I discovered Ayurvedic medicine a few years ago. Ayurveda, or Ayurvedic Medicine, is a therapeutic system created in India about 5000 years ago. In Sanskrit the word “Ayurveda” is a combination of two words “ayur”, which means “life” and “veda”, which means “science”. … Type: Startup Activities: biotech cosmetics deeptech Technologies: Bio sourced materials Synthetic Biology | 1 | 1 | 0 | 1 |